SlideShare a Scribd company logo
ELIMINATION
Of Drugs
By
GOWTHAMRAJ.S , B.pharm,
EXCEL COLLEGE OF PHARMACY.
DRUG ELIMINATION:
❖ Drugs are removed from the body by various elimination
processes.
❖ It is defined as the irreversible loss of drug from the
body.
❖ It occurs by two processes:
METABOLISM EXCRETION
ELIMINATION = METABOLISM + EXCRETIONN
DRUG
METABOLISM
METABOLISM OF DRUGS:
❖ It is also called as BIOTRANSFORMATION
❖ It is defined as the biochemical modification of a drug in the body.
❖ Once drug enters the body it undergoes ABSORPTION,
DISTRIBUTION,METABOLISM, ELIMINATION.
❖ METABOLISM is an important process which reduces the toxicity of
the Drug in the body.
Protein soluble ------> water soluble
SITES OF METABOLISM:
❖ LIVER ( primary sites )
❖ GIT
❖ LUNGS
❖ KIDNEYS
❖ SKINS
ENZYMES INVOLVED IN METABOLISM:
PHASE I METABOLISM
★ Cytochrome P450.
★ Flavin containing mono
oxygenase(FMO)
★ Esterase
★ Alcohol
dehydrogenase(ADH)
★ Aldehyde
dehydrogenase(ALDH)
★ Monoamine oxidase (MAO)
PHASE II METABOLISM
★ Uridine diphosphate
glucuronosyltransferase
(UDPGT)
★ Sulfotransferase (ST)
★ N- Acetyltransferase (NAT)
★ Glutathione S- Transferase
(GST)
★ Methyl Transferase
★ Amino acid conjunction
METABOLIC PATHWAYS:
It is divided into two phases,
METABOLISM
PHASE I PHASE II
★ OXIDATION
★ REDUCTION
★ HYDROLYSIS
★ SULPHONATION
★ ACETYLATION
★ METHYLATION
★ GLUTATHIONE
CONJUGATION
★ GLUCURONIDATION
PHASE I METABOLISM:
❖ A molecule of drug initially enters into the PHASE I METABOLISM
❖ It undergoes sequence of reactions
❖ Attachment of functional groups to the drugs like -OH,-SH,-NH2
❖ It helps in the CONJUGATION of drug in PHASE II easily.
❖ Converts itself into forms that shows reduced solubility in lipids as well
as in water so that it's excretion is facilitated.
REACTIONS:
★ OXIDATION
★ REDUCTION
★ HYDROLYSIS
OXIDATION:
❖ Liver cells are the most common site for OXIDATION.
❖ Oxidation involves conversion of a C-H bond to a C-OH.
❖ This reaction sometimes converts a pharmacologically inactive
compound (a prodrug) to a pharmacologically active one.
❖ By the same token, Phase I can turn a nontoxic molecule into a
poisonous one (toxification).
RH + O2 + NADPH + H+ --------> ROH + H2O + NADP+
REDUCTION:
❖ Drugs containing an aldehyde,ketone , disulphide,quinine,N- oxide
,alkene ,azo or Nitro group undergo In Vivo reduction.
❖ Alcohol dehydrogenation < ------ > carbonyl reduction
❖ N- Oxidation < ------- > Amine oxide reduction
Eg:
HYDROLYSIS:
❖ Cleavage of drug molecule by taking up a molecule of water.
SITES :
★ Liver
★ Intestines
★ Plasma
★ Other tissues
Eg.
PHASE II METABOLISM:
❖ In PHASE II reactions,drugs are combined with hydrophilic
endogenous compound to form complex which allows rapids excretion.
❖ It is also called as CONJUGATION REACTIONS.
❖ PHASE II reactions are much faster than PHASE I reactions.
★ SULPHONATION
★ ACETYLATION
★ METHYLATION
★ GLUTATHIONE
CONJUGATION
★ GLUCURONIDATION
Glucuronidation -OH,-COOH,-NH2, ,-SH,-CH,-NH
Sulphonation Aromatic-OH,Aromatic -NH2,alcohols
Acetylation Hydrazine,-SO2,,-NH2
Methylation Aromatic -OH ,-NH2 ,-NH,-SH
Glutathione
conjunction
Epoxides and organic halides
Glycine conjunction Aromatic-NH2, and -COOH
CONJUGATION REACTIONS & FUNCTIONAL GROUPS
GLUCURONIDATION:
❖ GLUCURONIDATION is quantitatively the most significant PHASE II
reaction.
❖ Glucuronic acid conjunction occurs only when glucuronic acid gets
activated.
Eg: O - Glucuronides
FACTORS AFFECTING DRUG METABOLISM:
❖ Biological factor's
➢ Age
➢ Diet
➢ Sex
➢ Weight
➢ Others
➢ Body temperature
❖ Chemical factor's
➢ Enzyme inhibitors
➢ Enzyme stimulators
❖ Physico chemical properties of drug
DRUG
EXCRETION
EXCRETION:
❖ EXCRETION remove the drugs or their metabolites from the body.
❖ KIDNEYS are the principal organs for excretion.
❖ The other organs include lungs,biliary system, intestines,salivary
gland, sweat glands.
❖ All lipid soluble drugs are converted into water soluble compounds by
the metabolic process which favours the excretion process.
CLEARANCE:
DEFINITION:
❖ It is defined as the complete removal of a drug in a specified time
period from the hypothetical volume of body fluids containing the
drug.
UNIT:. ml/min
It describes the relationship between plasma drug concentration and the
rate of drug elimination.
Elimination rate
Clearance(cl)= ----------------------------------
Plasma drug concentration
RENAL CLEARANCE:
❖ The clearance takes place in kidney are called as RENAL CLEARANCE.
❖ Blood volume or plasma volume, completely cleared of the drug in its
unchanged from , by the kidneys per unit time.
❖ Clearance is a measure of renal function.
Rate of urinary excretion
ClR = -----------------------------------
Plasma drug concentration
Rate of filtration+rate of secretion - rate of reabsorption
ClR = -----------------------------------------------------------------------------
C
EXCRETION OF DRUGS
Renal Excretion of Drugs Non - Renal Excretion of Drug
★ The excretion of drugs by the
KIDNEYS.
★ Eg: drugs like gentamicin
★ In this excretion, drugs are
removed via Urine.
★ The excretion of drugs by all
other routes except the Renal
route( kidney).
★ It involves
○ Biliary excretion
○ Pulmonary excretion
○ Salivary excretion
○ Mammary excretion
○ Skin excretion
○ Gastrointestinal excretion
RENAL EXCRETION
RENAL EXCRETION:
❖ Kidneys are responsible for the excretion of nearly all drugs as well as
their metabolites.
❖ Water soluble, non volatile, small molecule size (<500 Dalton's) are
undergo excretion via Urine.
❖ NEPHRON is the basic functional unit of kidney. One million Nephrons
are present in each kidney.
Rate of Rate of Rate of Rate of
Excretion = Filtration + Secretion - Reabsorption
PRINCIPLE OF RENAL MECHANISM INVOLVED:
❖ GLOMERULAR FILTRATION
❖ TUBULAR SECRETION
❖ TUBULAR REABSORPTION
GLOMERULAR FILTRATION:
❖ Most compounds are filtered except that are bound
to plasma protein's
❖ Non - selective process
❖ Occurs in only one direction
❖ Glomerulus behaves as negatively charged
❖ Hydrostatic pressure of blood flowing in the
capillaries acts as driving force for filtration.
❖ Only 10% of cardiac output is filtered through
glomeruli.
❖ The rate of filtration is known as GLOMERULAR
FILTRATION RATE (GFR)
❖ Compounds with 20Å to 42Å may undergo Glomerular
filtration.
❖ Substance used for determination of GFR:
➢ Creatinine
➢ Inulin
➢ Mannitol
➢ Sodium thiosulphate
ACTIVE TUBULAR SECRETION:
❖ It is a carrier mediated process.
❖ Compounds are transported in a opposite direction to
the concentration gradient by utilising energy.
TWO SECRETION MECHANISM
1.System for secretion of organic acids/ anions
Eg. penicillin, Salicylate, etc…
2.System for organic base / cations
Eg. Morphine, mecamylamine, hexamethonium .
TUBULAR REABSORPTION:
❖ Site - takes place all along Renal tubules.
❖ Results in increases in half life of a drugs.
TWO TYPES:
❖ Active tubular reabsorption:
➢ High threshold endogenous substance or nutrients
which the body needs to preserve.
➢ Eg. Glucose , electrolytes,vitamins, amino acids,uric
acids.
➢ Drugs - oxopurinol
❖ Passive tubular reabsorption
➢ For exogenous substance like drugs.
➢ Concentration gradient takes place - driving force
➢ Lipophilic substance are extensively reabsorbed and
polar not reabsorbed.
REABSORPTION DEPENDS UPON:
● pH of Urine(4.5-7.5)
● Urine flow rate
● pKa of drug
FACTORS AFFECTING RENAL EXCRETION:
❖ Physico chemical properties
❖ Drug interactions
❖ Distribution and binding of drug
❖ Blood flow to kidney
❖ Urine pH
❖ Disease state
❖ Biological factor's
❖ Plasma concentrations
1. Physico chemical properties
a. Molecular size
i. Size <300 Dalton's
ii. Excretion of drugs with larger molecular weight is difficult
compared to that of drugs with smaller weights.
b. Lipid solubility
i. Inversely proportional to the urinary excretion
c. Volume of distribution
i. Inversely proportional to the clearance
ii. Lage Vd - poor Excretion in Urine
iii. Small Vd - high excretion in Urine
2. Plasma concentrations of drug
● Glomerular filtration and reabsorption are directly affected by
plasma concentrations
3.Biological factor's
● Renal Excretion is 10% lower in females.
● New born : 30-40% less
● Old age : excretion decreased, increased t1/2.
NON RENAL EXCRETION
BILIARY EXCRETION OF DRUGS / ENTEROHEPATIC CYCLING
❖ Production and secretion of bile is active proces.
❖ Bile secreted in the liver , stored in gall bladder and released in the
duodenum.
❖ Bile significantly helps in digestion and absorption of fats.
❖ Secretion of bile is a capacity limited process and gets saturated.
Drug concentration in bile (less)
Drug concentration in plasma (higher)
Biliary clearance is low.
Vice-versa…..
Based on their bile / plasma concentrations ratio's, the compounds
excreted in bile can be grouped.
GROUPS Bile / plasma
concentrations
Example
GROUP A About 1 Sodium,potassium,chl
oride,glucose
GROUP B More than 1 Bile salts, creatinine,
bilirubin Glucuronides.
GROUP C Less than 1 Sucrose, inulin,
phosphate,
phospholipid.
ENTERO HEPATIC CIRCULATION OR CYCLING:
❖ The phenomenon of drug circulation between the intestines and the
liver is called ENTEROHEPATIC CYCLING or CIRCULATION.
❖ Half life - t1/2 - INCREASED
for drugs.
❖ Prolongation of drug action
❖ Eg. Cardiac glycosides ,
rifampicin,
chlorpromazine,
indomethacin.
PULMONARY EXCRETION OF DRUGS:
❖ Gaseous and volatile substance such as general anaesthetics
(Halothane) are absorbed through lungs by simple diffusion.
❖ Pulmonary blood flow ,rate of respirations and solubility of substance
affect the pulmonary excretion.
❖ Alcohol which has high solubility in blood and tissues are excreted
slowly by lungs.
Eg: General anaesthetics - Halothane,
nitrous oxide
Alcohol - excreted slowly through
lungs
SALIVARY EXCRETION OF DRUGS
❖ It involves Excretion of drugs through saliva by the process of passive
diffusion.
❖ The pH of Saliva varies from 5.8 to 8.4
❖ Unionised lipid soluble drug's are excreted passively
❖ The bitter taste is due to drug excreted
❖ For weak acid ratio's found to be <1
❖ For weak base ratio's found to be >1
❖ Eg . Sulphonamides , antibiotics, clonidine ,etc...
MAMMARY EXCRETION OF DRUGS:
❖ A drug that is excreted in milk can enter in infants feeding.
❖ pH of milk ranges from 6.4-7.6 and a mean pH of 7.0
❖ Un ionised , lipid soluble drugs show Passive diffusion in the alveolar
cells of the mammary gland.
❖ The excretion of drugs in milk is usually less than 1%.
❖ Milk bears an acidic nature as compared to plasma.
❖ Drugs are weak basic in nature show greater concentration in milk.
Eg. Chloramphenicol , diazepam , tetracyclines, etc...
DRUG EXCRETION IN MILK DEPENDS ON
★ pH partition behaviour
★ Molecular weight
★ Lipid solubility
★ Degree of ionisation
EFFECTS
★ Some potent drugs may induce toxicity in infants.i.e
barbiturates,morphine , ergotamine.
★ Whenever possible, feeding mothers should avoid drugs .
★ If medication is unavoidable, the infant should be bottle fed.
SKIN EXCRETION OF DRUGS
❖ It depends on pH partition hypothesis
❖ Passively excreted through skin
❖ Sweat : urea derivatives, amines , heavy metals.
Eg : benzoic acid, Salicylic acid,
alcohol.
GASTROINTESTINAL EXCRETION OF DRUGS
❖ GI excretion takes place when drug administered through parenteral
route.
❖ It undergoes passive diffusion
❖ GIT also shows the absorption and excretion of drugs that are
administered orally.
❖ Stomach is the specific site that shows the excretion of water soluble
and ionised forms of drugs that either weak acid or base.
Eg. Nicotine, quinine, magnesium sulphate, streptomycin neomycin,
cholestyramine etc...
SUMMARY
Thank you!!!

More Related Content

What's hot

Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.ppt
ramchoure90
 
Factors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of DrugsFactors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of Drugs
wonderingsoul114
 
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
DR. METI.BHARATH KUMAR
 
Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1
Sulekha Rohilla
 
Causes of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsCauses of Non linear pharmacokinetics
Causes of Non linear pharmacokinetics
Snehal Patel
 
Measurement of bioavailability
Measurement of bioavailabilityMeasurement of bioavailability
Measurement of bioavailability
shikha singh
 
Bioavailability and bioequivalence
Bioavailability and bioequivalenceBioavailability and bioequivalence
Bioavailability and bioequivalence
Suvarta Maru
 
Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
Naresh Gorantla
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug Absorption
SURYAKANTVERMA2
 
Bioavailability and bioequivalence
Bioavailability and bioequivalenceBioavailability and bioequivalence
Bioavailability and bioequivalence
Naresh Gorantla
 
Kinetics of multiple dosing
Kinetics of multiple dosingKinetics of multiple dosing
Kinetics of multiple dosing
PreetiPatilVibhute
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretion
chiranjibi68
 
Methods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugsMethods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugs
Debasish Ghadei
 
Methods of enhancing Dissolution and bioavailability of poorly soluble drugs
Methods of enhancing Dissolution and bioavailability of poorly soluble drugsMethods of enhancing Dissolution and bioavailability of poorly soluble drugs
Methods of enhancing Dissolution and bioavailability of poorly soluble drugs
Ram Kanth
 
Methods for Measurement of bioavailability
Methods for Measurement of bioavailability Methods for Measurement of bioavailability
Methods for Measurement of bioavailability
pharmacampus
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
Sujit Patel
 
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Dr K SUDHEER KUMAR KANDIBANDA
 
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
DR. METI.BHARATH KUMAR
 
Evaluation of Herbal Drugs unit 4
Evaluation of Herbal Drugs unit 4Evaluation of Herbal Drugs unit 4
Evaluation of Herbal Drugs unit 4
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 

What's hot (20)

Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.ppt
 
Factors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of DrugsFactors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of Drugs
 
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
 
Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1
 
Causes of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsCauses of Non linear pharmacokinetics
Causes of Non linear pharmacokinetics
 
Measurement of bioavailability
Measurement of bioavailabilityMeasurement of bioavailability
Measurement of bioavailability
 
Bioavailability and bioequivalence
Bioavailability and bioequivalenceBioavailability and bioequivalence
Bioavailability and bioequivalence
 
Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug Absorption
 
Bioavailability and bioequivalence
Bioavailability and bioequivalenceBioavailability and bioequivalence
Bioavailability and bioequivalence
 
Kinetics of multiple dosing
Kinetics of multiple dosingKinetics of multiple dosing
Kinetics of multiple dosing
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretion
 
Methods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugsMethods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugs
 
Methods of enhancing Dissolution and bioavailability of poorly soluble drugs
Methods of enhancing Dissolution and bioavailability of poorly soluble drugsMethods of enhancing Dissolution and bioavailability of poorly soluble drugs
Methods of enhancing Dissolution and bioavailability of poorly soluble drugs
 
Methods for Measurement of bioavailability
Methods for Measurement of bioavailability Methods for Measurement of bioavailability
Methods for Measurement of bioavailability
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
Evaluation of Drugs WHO &ICH Guidelines for The Assessment of Herbal Drugs st...
 
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
 
Evaluation of Herbal Drugs unit 4
Evaluation of Herbal Drugs unit 4Evaluation of Herbal Drugs unit 4
Evaluation of Herbal Drugs unit 4
 

Similar to ELIMINATION OF DRUGS BIOPHARMACEUTICS

c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...
c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...
c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...
NarayanRajaramkote
 
Drugexcretion 130121005834-phpapp01
Drugexcretion 130121005834-phpapp01Drugexcretion 130121005834-phpapp01
Drugexcretion 130121005834-phpapp01
suhasini
 
Elimination.pptx
Elimination.pptxElimination.pptx
Elimination.pptx
Prathamesh Patil
 
Excretion of drugs
Excretion of drugsExcretion of drugs
Excretion of drugs
PraveenGujjulaPravee
 
Excretion of drugs
Excretion of drugsExcretion of drugs
Excretion of drugs
PraveenGujjulaPravee
 
Drug Elimination
Drug EliminationDrug Elimination
Drug Elimination
Nita Deore
 
Pharmacokinetics - II.pptx
Pharmacokinetics - II.pptxPharmacokinetics - II.pptx
Pharmacokinetics - II.pptx
Dr.Arun Marshalin
 
Metabolism and Excretion.pptx
Metabolism and Excretion.pptxMetabolism and Excretion.pptx
Metabolism and Excretion.pptx
chetanadakhare
 
pharmacokinetics-ii-170215132744.pdf
pharmacokinetics-ii-170215132744.pdfpharmacokinetics-ii-170215132744.pdf
pharmacokinetics-ii-170215132744.pdf
safa98
 
Pharmacokinetics ii
Pharmacokinetics  iiPharmacokinetics  ii
Pharmacokinetics ii
Dr. Pooja
 
Clearance & Elimination detail explanation.pptx
Clearance & Elimination detail explanation.pptxClearance & Elimination detail explanation.pptx
Clearance & Elimination detail explanation.pptx
UVAS
 
drug elimination kinetics in pharmacology
drug elimination kinetics in pharmacologydrug elimination kinetics in pharmacology
drug elimination kinetics in pharmacology
GauravChatterjee13
 
Drug excretion lecture 10
Drug excretion  lecture 10Drug excretion  lecture 10
Drug excretion lecture 10homebwoi
 
Drug eliminationvpp
Drug eliminationvppDrug eliminationvpp
Drug eliminationvpp
Virupanagouda patil
 
biotransformation
 biotransformation  biotransformation
biotransformation
zeelmevada
 
Excretion edited
Excretion editedExcretion edited
Excretion edited
mizan00
 
Drug Elimnation.pptx
Drug Elimnation.pptxDrug Elimnation.pptx
Pharmacokinetics / Biopharmaceutics - Drug Elimination
Pharmacokinetics / Biopharmaceutics - Drug Elimination Pharmacokinetics / Biopharmaceutics - Drug Elimination
Pharmacokinetics / Biopharmaceutics - Drug Elimination
Areej Abu Hanieh
 

Similar to ELIMINATION OF DRUGS BIOPHARMACEUTICS (20)

c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...
c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...
c ADVANCED BIOPHARMACEUTICS AND PHARMACOKINETICS PRESENTATION BY- NARAYAN R K...
 
Drugexcretion 130121005834-phpapp01
Drugexcretion 130121005834-phpapp01Drugexcretion 130121005834-phpapp01
Drugexcretion 130121005834-phpapp01
 
Elimination.pptx
Elimination.pptxElimination.pptx
Elimination.pptx
 
Excretion of drugs
Excretion of drugsExcretion of drugs
Excretion of drugs
 
Excretion of drugs
Excretion of drugsExcretion of drugs
Excretion of drugs
 
Excretion of drug (VK)
Excretion of drug (VK)Excretion of drug (VK)
Excretion of drug (VK)
 
Drug Elimination
Drug EliminationDrug Elimination
Drug Elimination
 
Pharmacokinetics - II.pptx
Pharmacokinetics - II.pptxPharmacokinetics - II.pptx
Pharmacokinetics - II.pptx
 
excretion
excretionexcretion
excretion
 
Metabolism and Excretion.pptx
Metabolism and Excretion.pptxMetabolism and Excretion.pptx
Metabolism and Excretion.pptx
 
pharmacokinetics-ii-170215132744.pdf
pharmacokinetics-ii-170215132744.pdfpharmacokinetics-ii-170215132744.pdf
pharmacokinetics-ii-170215132744.pdf
 
Pharmacokinetics ii
Pharmacokinetics  iiPharmacokinetics  ii
Pharmacokinetics ii
 
Clearance & Elimination detail explanation.pptx
Clearance & Elimination detail explanation.pptxClearance & Elimination detail explanation.pptx
Clearance & Elimination detail explanation.pptx
 
drug elimination kinetics in pharmacology
drug elimination kinetics in pharmacologydrug elimination kinetics in pharmacology
drug elimination kinetics in pharmacology
 
Drug excretion lecture 10
Drug excretion  lecture 10Drug excretion  lecture 10
Drug excretion lecture 10
 
Drug eliminationvpp
Drug eliminationvppDrug eliminationvpp
Drug eliminationvpp
 
biotransformation
 biotransformation  biotransformation
biotransformation
 
Excretion edited
Excretion editedExcretion edited
Excretion edited
 
Drug Elimnation.pptx
Drug Elimnation.pptxDrug Elimnation.pptx
Drug Elimnation.pptx
 
Pharmacokinetics / Biopharmaceutics - Drug Elimination
Pharmacokinetics / Biopharmaceutics - Drug Elimination Pharmacokinetics / Biopharmaceutics - Drug Elimination
Pharmacokinetics / Biopharmaceutics - Drug Elimination
 

More from NEW ROYAL CARE PHARMACY, SALEM, TAMILNADU, INDIA - 636011

STABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptx
STABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptxSTABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptx
STABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptx
NEW ROYAL CARE PHARMACY, SALEM, TAMILNADU, INDIA - 636011
 
FAIRNESS CREAM.pptx
FAIRNESS CREAM.pptxFAIRNESS CREAM.pptx
RESPIRATORY SYSTEM - PHARMACOLOGY
RESPIRATORY SYSTEM - PHARMACOLOGYRESPIRATORY SYSTEM - PHARMACOLOGY
HPTLC.pptx
HPTLC.pptxHPTLC.pptx
DRUGS FOR DIARRHOEA
DRUGS FOR DIARRHOEADRUGS FOR DIARRHOEA
CHOLERA - Acute diarrhoeal disease
CHOLERA - Acute diarrhoeal diseaseCHOLERA - Acute diarrhoeal disease

More from NEW ROYAL CARE PHARMACY, SALEM, TAMILNADU, INDIA - 636011 (6)

STABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptx
STABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptxSTABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptx
STABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptx
 
FAIRNESS CREAM.pptx
FAIRNESS CREAM.pptxFAIRNESS CREAM.pptx
FAIRNESS CREAM.pptx
 
RESPIRATORY SYSTEM - PHARMACOLOGY
RESPIRATORY SYSTEM - PHARMACOLOGYRESPIRATORY SYSTEM - PHARMACOLOGY
RESPIRATORY SYSTEM - PHARMACOLOGY
 
HPTLC.pptx
HPTLC.pptxHPTLC.pptx
HPTLC.pptx
 
DRUGS FOR DIARRHOEA
DRUGS FOR DIARRHOEADRUGS FOR DIARRHOEA
DRUGS FOR DIARRHOEA
 
CHOLERA - Acute diarrhoeal disease
CHOLERA - Acute diarrhoeal diseaseCHOLERA - Acute diarrhoeal disease
CHOLERA - Acute diarrhoeal disease
 

Recently uploaded

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 

Recently uploaded (20)

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 

ELIMINATION OF DRUGS BIOPHARMACEUTICS

  • 1. ELIMINATION Of Drugs By GOWTHAMRAJ.S , B.pharm, EXCEL COLLEGE OF PHARMACY.
  • 2. DRUG ELIMINATION: ❖ Drugs are removed from the body by various elimination processes. ❖ It is defined as the irreversible loss of drug from the body. ❖ It occurs by two processes: METABOLISM EXCRETION ELIMINATION = METABOLISM + EXCRETIONN
  • 3.
  • 5. METABOLISM OF DRUGS: ❖ It is also called as BIOTRANSFORMATION ❖ It is defined as the biochemical modification of a drug in the body. ❖ Once drug enters the body it undergoes ABSORPTION, DISTRIBUTION,METABOLISM, ELIMINATION. ❖ METABOLISM is an important process which reduces the toxicity of the Drug in the body. Protein soluble ------> water soluble
  • 6. SITES OF METABOLISM: ❖ LIVER ( primary sites ) ❖ GIT ❖ LUNGS ❖ KIDNEYS ❖ SKINS
  • 7. ENZYMES INVOLVED IN METABOLISM: PHASE I METABOLISM ★ Cytochrome P450. ★ Flavin containing mono oxygenase(FMO) ★ Esterase ★ Alcohol dehydrogenase(ADH) ★ Aldehyde dehydrogenase(ALDH) ★ Monoamine oxidase (MAO) PHASE II METABOLISM ★ Uridine diphosphate glucuronosyltransferase (UDPGT) ★ Sulfotransferase (ST) ★ N- Acetyltransferase (NAT) ★ Glutathione S- Transferase (GST) ★ Methyl Transferase ★ Amino acid conjunction
  • 8. METABOLIC PATHWAYS: It is divided into two phases, METABOLISM PHASE I PHASE II ★ OXIDATION ★ REDUCTION ★ HYDROLYSIS ★ SULPHONATION ★ ACETYLATION ★ METHYLATION ★ GLUTATHIONE CONJUGATION ★ GLUCURONIDATION
  • 9.
  • 10. PHASE I METABOLISM: ❖ A molecule of drug initially enters into the PHASE I METABOLISM ❖ It undergoes sequence of reactions ❖ Attachment of functional groups to the drugs like -OH,-SH,-NH2 ❖ It helps in the CONJUGATION of drug in PHASE II easily. ❖ Converts itself into forms that shows reduced solubility in lipids as well as in water so that it's excretion is facilitated. REACTIONS: ★ OXIDATION ★ REDUCTION ★ HYDROLYSIS
  • 11. OXIDATION: ❖ Liver cells are the most common site for OXIDATION. ❖ Oxidation involves conversion of a C-H bond to a C-OH. ❖ This reaction sometimes converts a pharmacologically inactive compound (a prodrug) to a pharmacologically active one. ❖ By the same token, Phase I can turn a nontoxic molecule into a poisonous one (toxification). RH + O2 + NADPH + H+ --------> ROH + H2O + NADP+
  • 12.
  • 13. REDUCTION: ❖ Drugs containing an aldehyde,ketone , disulphide,quinine,N- oxide ,alkene ,azo or Nitro group undergo In Vivo reduction. ❖ Alcohol dehydrogenation < ------ > carbonyl reduction ❖ N- Oxidation < ------- > Amine oxide reduction Eg:
  • 14. HYDROLYSIS: ❖ Cleavage of drug molecule by taking up a molecule of water. SITES : ★ Liver ★ Intestines ★ Plasma ★ Other tissues Eg.
  • 15. PHASE II METABOLISM: ❖ In PHASE II reactions,drugs are combined with hydrophilic endogenous compound to form complex which allows rapids excretion. ❖ It is also called as CONJUGATION REACTIONS. ❖ PHASE II reactions are much faster than PHASE I reactions. ★ SULPHONATION ★ ACETYLATION ★ METHYLATION ★ GLUTATHIONE CONJUGATION ★ GLUCURONIDATION
  • 16. Glucuronidation -OH,-COOH,-NH2, ,-SH,-CH,-NH Sulphonation Aromatic-OH,Aromatic -NH2,alcohols Acetylation Hydrazine,-SO2,,-NH2 Methylation Aromatic -OH ,-NH2 ,-NH,-SH Glutathione conjunction Epoxides and organic halides Glycine conjunction Aromatic-NH2, and -COOH CONJUGATION REACTIONS & FUNCTIONAL GROUPS
  • 17. GLUCURONIDATION: ❖ GLUCURONIDATION is quantitatively the most significant PHASE II reaction. ❖ Glucuronic acid conjunction occurs only when glucuronic acid gets activated. Eg: O - Glucuronides
  • 18. FACTORS AFFECTING DRUG METABOLISM: ❖ Biological factor's ➢ Age ➢ Diet ➢ Sex ➢ Weight ➢ Others ➢ Body temperature ❖ Chemical factor's ➢ Enzyme inhibitors ➢ Enzyme stimulators ❖ Physico chemical properties of drug
  • 20. EXCRETION: ❖ EXCRETION remove the drugs or their metabolites from the body. ❖ KIDNEYS are the principal organs for excretion. ❖ The other organs include lungs,biliary system, intestines,salivary gland, sweat glands. ❖ All lipid soluble drugs are converted into water soluble compounds by the metabolic process which favours the excretion process.
  • 21. CLEARANCE: DEFINITION: ❖ It is defined as the complete removal of a drug in a specified time period from the hypothetical volume of body fluids containing the drug. UNIT:. ml/min It describes the relationship between plasma drug concentration and the rate of drug elimination. Elimination rate Clearance(cl)= ---------------------------------- Plasma drug concentration
  • 22. RENAL CLEARANCE: ❖ The clearance takes place in kidney are called as RENAL CLEARANCE. ❖ Blood volume or plasma volume, completely cleared of the drug in its unchanged from , by the kidneys per unit time. ❖ Clearance is a measure of renal function. Rate of urinary excretion ClR = ----------------------------------- Plasma drug concentration Rate of filtration+rate of secretion - rate of reabsorption ClR = ----------------------------------------------------------------------------- C
  • 23. EXCRETION OF DRUGS Renal Excretion of Drugs Non - Renal Excretion of Drug ★ The excretion of drugs by the KIDNEYS. ★ Eg: drugs like gentamicin ★ In this excretion, drugs are removed via Urine. ★ The excretion of drugs by all other routes except the Renal route( kidney). ★ It involves ○ Biliary excretion ○ Pulmonary excretion ○ Salivary excretion ○ Mammary excretion ○ Skin excretion ○ Gastrointestinal excretion
  • 25. RENAL EXCRETION: ❖ Kidneys are responsible for the excretion of nearly all drugs as well as their metabolites. ❖ Water soluble, non volatile, small molecule size (<500 Dalton's) are undergo excretion via Urine. ❖ NEPHRON is the basic functional unit of kidney. One million Nephrons are present in each kidney. Rate of Rate of Rate of Rate of Excretion = Filtration + Secretion - Reabsorption
  • 26.
  • 27. PRINCIPLE OF RENAL MECHANISM INVOLVED: ❖ GLOMERULAR FILTRATION ❖ TUBULAR SECRETION ❖ TUBULAR REABSORPTION
  • 28. GLOMERULAR FILTRATION: ❖ Most compounds are filtered except that are bound to plasma protein's ❖ Non - selective process ❖ Occurs in only one direction ❖ Glomerulus behaves as negatively charged ❖ Hydrostatic pressure of blood flowing in the capillaries acts as driving force for filtration. ❖ Only 10% of cardiac output is filtered through glomeruli.
  • 29. ❖ The rate of filtration is known as GLOMERULAR FILTRATION RATE (GFR) ❖ Compounds with 20Å to 42Å may undergo Glomerular filtration. ❖ Substance used for determination of GFR: ➢ Creatinine ➢ Inulin ➢ Mannitol ➢ Sodium thiosulphate
  • 30. ACTIVE TUBULAR SECRETION: ❖ It is a carrier mediated process. ❖ Compounds are transported in a opposite direction to the concentration gradient by utilising energy. TWO SECRETION MECHANISM 1.System for secretion of organic acids/ anions Eg. penicillin, Salicylate, etc… 2.System for organic base / cations Eg. Morphine, mecamylamine, hexamethonium .
  • 31. TUBULAR REABSORPTION: ❖ Site - takes place all along Renal tubules. ❖ Results in increases in half life of a drugs. TWO TYPES: ❖ Active tubular reabsorption: ➢ High threshold endogenous substance or nutrients which the body needs to preserve. ➢ Eg. Glucose , electrolytes,vitamins, amino acids,uric acids. ➢ Drugs - oxopurinol
  • 32. ❖ Passive tubular reabsorption ➢ For exogenous substance like drugs. ➢ Concentration gradient takes place - driving force ➢ Lipophilic substance are extensively reabsorbed and polar not reabsorbed. REABSORPTION DEPENDS UPON: ● pH of Urine(4.5-7.5) ● Urine flow rate ● pKa of drug
  • 33. FACTORS AFFECTING RENAL EXCRETION: ❖ Physico chemical properties ❖ Drug interactions ❖ Distribution and binding of drug ❖ Blood flow to kidney ❖ Urine pH ❖ Disease state ❖ Biological factor's ❖ Plasma concentrations
  • 34. 1. Physico chemical properties a. Molecular size i. Size <300 Dalton's ii. Excretion of drugs with larger molecular weight is difficult compared to that of drugs with smaller weights. b. Lipid solubility i. Inversely proportional to the urinary excretion c. Volume of distribution i. Inversely proportional to the clearance ii. Lage Vd - poor Excretion in Urine iii. Small Vd - high excretion in Urine
  • 35. 2. Plasma concentrations of drug ● Glomerular filtration and reabsorption are directly affected by plasma concentrations 3.Biological factor's ● Renal Excretion is 10% lower in females. ● New born : 30-40% less ● Old age : excretion decreased, increased t1/2.
  • 37. BILIARY EXCRETION OF DRUGS / ENTEROHEPATIC CYCLING ❖ Production and secretion of bile is active proces. ❖ Bile secreted in the liver , stored in gall bladder and released in the duodenum. ❖ Bile significantly helps in digestion and absorption of fats. ❖ Secretion of bile is a capacity limited process and gets saturated. Drug concentration in bile (less) Drug concentration in plasma (higher) Biliary clearance is low. Vice-versa…..
  • 38. Based on their bile / plasma concentrations ratio's, the compounds excreted in bile can be grouped. GROUPS Bile / plasma concentrations Example GROUP A About 1 Sodium,potassium,chl oride,glucose GROUP B More than 1 Bile salts, creatinine, bilirubin Glucuronides. GROUP C Less than 1 Sucrose, inulin, phosphate, phospholipid.
  • 39. ENTERO HEPATIC CIRCULATION OR CYCLING: ❖ The phenomenon of drug circulation between the intestines and the liver is called ENTEROHEPATIC CYCLING or CIRCULATION. ❖ Half life - t1/2 - INCREASED for drugs. ❖ Prolongation of drug action ❖ Eg. Cardiac glycosides , rifampicin, chlorpromazine, indomethacin.
  • 40.
  • 41. PULMONARY EXCRETION OF DRUGS: ❖ Gaseous and volatile substance such as general anaesthetics (Halothane) are absorbed through lungs by simple diffusion. ❖ Pulmonary blood flow ,rate of respirations and solubility of substance affect the pulmonary excretion. ❖ Alcohol which has high solubility in blood and tissues are excreted slowly by lungs. Eg: General anaesthetics - Halothane, nitrous oxide Alcohol - excreted slowly through lungs
  • 42. SALIVARY EXCRETION OF DRUGS ❖ It involves Excretion of drugs through saliva by the process of passive diffusion. ❖ The pH of Saliva varies from 5.8 to 8.4 ❖ Unionised lipid soluble drug's are excreted passively ❖ The bitter taste is due to drug excreted
  • 43. ❖ For weak acid ratio's found to be <1 ❖ For weak base ratio's found to be >1 ❖ Eg . Sulphonamides , antibiotics, clonidine ,etc...
  • 44. MAMMARY EXCRETION OF DRUGS: ❖ A drug that is excreted in milk can enter in infants feeding. ❖ pH of milk ranges from 6.4-7.6 and a mean pH of 7.0 ❖ Un ionised , lipid soluble drugs show Passive diffusion in the alveolar cells of the mammary gland. ❖ The excretion of drugs in milk is usually less than 1%. ❖ Milk bears an acidic nature as compared to plasma. ❖ Drugs are weak basic in nature show greater concentration in milk. Eg. Chloramphenicol , diazepam , tetracyclines, etc...
  • 45. DRUG EXCRETION IN MILK DEPENDS ON ★ pH partition behaviour ★ Molecular weight ★ Lipid solubility ★ Degree of ionisation EFFECTS ★ Some potent drugs may induce toxicity in infants.i.e barbiturates,morphine , ergotamine. ★ Whenever possible, feeding mothers should avoid drugs . ★ If medication is unavoidable, the infant should be bottle fed.
  • 46. SKIN EXCRETION OF DRUGS ❖ It depends on pH partition hypothesis ❖ Passively excreted through skin ❖ Sweat : urea derivatives, amines , heavy metals. Eg : benzoic acid, Salicylic acid, alcohol.
  • 47. GASTROINTESTINAL EXCRETION OF DRUGS ❖ GI excretion takes place when drug administered through parenteral route. ❖ It undergoes passive diffusion ❖ GIT also shows the absorption and excretion of drugs that are administered orally. ❖ Stomach is the specific site that shows the excretion of water soluble and ionised forms of drugs that either weak acid or base. Eg. Nicotine, quinine, magnesium sulphate, streptomycin neomycin, cholestyramine etc...